Fang Ni
2022
In 2022, Fang Ni earned a total compensation of $909.8K as Chief Business Officer and Chief Financial Officer at Black Diamond Therapeutics, a 46% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $196,977 |
|---|---|
| Option Awards | $253,426 |
| Salary | $411,740 |
| Other | $47,616 |
| Total | $909,759 |
Ni received $411.7K in salary, accounting for 45% of the total pay in 2022.
Ni also received $197K in non-equity incentive plan, $253.4K in option awards and $47.6K in other compensation.
Rankings
In 2022, Fang Ni's compensation ranked 3,227th out of 5,697 executives tracked by ExecPay. In other words, Ni earned more than 43.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,227 out of 5,697 | 43rd |
Division Manufacturing | 1,811 out of 3,099 | 42nd |
Major group Chemicals And Allied Products | 861 out of 1,406 | 39th |
Industry group Drugs | 805 out of 1,307 | 38th |
Industry Biological Products, Except Diagnostic Substances | 195 out of 291 | 33rd |
Source: SEC filing on April 4, 2023.
Ni's colleagues
We found two more compensation records of executives who worked with Fang Ni at Black Diamond Therapeutics in 2022.